Cymevene IV is indicated for the treatment of CMV retinitis in immunocompromised patiens, including patients with acquired immunodeficiency syndrome (AIDS). Cymevene IV is also indicated for the prevention of CMV disease in transplant recipients at risk for CMV disease.